Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz
Jake Chabon and Dave Kurtz of Foresight Diagnostics explain their novel PhasED-Seq MRD testing technology, which offers high sensitivity for detecting cancer relapse early, potentially reshaping cancer care standards and influencing NCCN guidelines.